AML still worth $1b and significantly derisked + orphan drug exclusivity. I would favour a CR ahead of dropping one program to fund another.
Ann: Bisantrene cGMP API Manufacturing Completed at Laurus Labs, page-74
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.59 |
Change
0.045(2.92%) |
Mkt cap ! $265.8M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.60 | $1.55 | $138.7K | 88.71K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1470 | $1.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.60 | 2500 | 1 |
View Market Depth
| Last trade - 12.20pm 10/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |